We also analyzed the PIEZO1 expression in cohorts differentiated by Scarff–Bloom–Richardson (SBR) grade, which reflects tumor grade and predicts prognosis in breast cancer patients. This evidence concerns the gene PIEZO1 and breast carcinoma.